Pharma
Follow
Find
42.0K views | +10 today
 
Scooped by Andrew Spong
onto Pharma
Scoop.it!

Corporate social media use: where will companies be in 5 years?

Corporate social media use: where will companies be in 5 years? | Pharma | Scoop.it

Dr. Nora Barnes of the UMAss Dartmouth Center for Marketing Research writes:

 

Our studies indicate that attention will move from a focus on tools to focus on measuring, monitoring and a discussion regarding the ROI of their social media efforts.

 

Companies will move from repositioning or retraining employees to handle the social media function to hiring social media professionals.

 

Social media plans will be as common as marketing plans for a company and budgets (including investments in software or consulting and hiring) will be clearly defined.

 

When sales/donations/recruits are committed, companies will be able to track the consumer to an initial social media contact with the company.

 

Companies will not necessarily continue with every tool they are currently using. Instead they will focus on those tools that have proven (through data collection, measuring, monitoring, tracking) to be the most beneficial for their goals. New tools will be introduced and current ones will change in terms of their primary users. Businesses will watch these changes and act accordingly.

 

Participating in a particular tool today will certainly not guarantee a company will choose that portal in the future. As our ability to measure the value of these channels improves, our decision making regarding our social media initiatives will change.

 

% of Fortune 500 blogging:

 

2007 (8%) 2008 (16%) 2009 (22%) 2010 (23%) 2011 (23%) and 2012 (28%). Companies blogging are consistently and slowing moving up.

 

% of Inc. 500 blogging:

2007 (19%), 2008 (39%), 2009 (45%), 2010 (50%) and 2011 (37%).

 

Last year was the first time we’ve seen a decline. The 2012 Inc. 500 study is coming out this fall.

more...
No comment yet.

From around the web

Pharma
Curating the writing of pharma's digital prescription
Curated by Andrew Spong
Your new post is loading...
Your new post is loading...
Rescooped by Andrew Spong from Patient
Scoop.it!

Healthcare is getting better. Let's talk about what you can do to make it even better, faster.

Healthcare is getting better. Let's talk about what you can do to make it even better, faster. | Pharma | Scoop.it

Click on the link above to contact Andrew Spong, Managing Director, STweM Ltd.

more...
Scooped by Andrew Spong
Scoop.it!

What would Samsung buying BlackBerry mean for healthcare?

What would Samsung buying BlackBerry mean for healthcare? | Pharma | Scoop.it
Andrew Spong's insight:

Tapping BlackBerry as part of a push into hospitals is a natural fit for Samsung, particularly because Apple just raised the stakes of the enterprise mobility game by inking a high-profile partnership with IBM, and healthcare was a big part of that push.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

68% of patients prefer pharma companies to interact with them through digital channels

68% of patients prefer pharma companies to interact with them through digital channels | Pharma | Scoop.it
more...
Helen Adams's curator insight, January 23, 4:33 AM

Only 68%!

Tanya Kerr's curator insight, January 23, 6:10 PM
This is a survey of US patients but the trend still has relevance to other markets
Scooped by Andrew Spong
Scoop.it!

Five new year's resolutions for digital health

Five new year's resolutions for digital health | Pharma | Scoop.it

Reforming the perverse and inhuman world of digital health

more...
XPert Patient's comment, December 22, 2014 1:52 PM
A very thought provoking article! I am of the view that 2015 will be the "Year of the Patient" on the social web. Patients are able to tune out of the hype and the "money-driven digital health orthodoxies." However, I do want to tune into news about genetic and genomic technologies which are revolutionising prognosis and treatment.

Regardless of digital health, we must always remember that medicine is a vocation. My late uncle who passed away this year, was a general surgeon working at the height of the Troubles in Northern Ireland. He saved countless lives in the operating theatres as staff attempted to hold the line under extraordinary strain. He frequently worked through day and night to aid victims of the latest shooting or bomb blast. He retired early from Gaelic Football to protect his "hands" - a surgeon of the highest rank, he was renowned for skill and speed. The local press in a tribute to him said " John O'Neill always led the field in things that really matter."

Let's hope that we all too can "hold the line" by standing up for what is right on the social web & just like my late uncle - lead the field in things that really matter in 2015.
Scooped by Andrew Spong
Scoop.it!

Patient engagement: the core of effective population health management

Engaging patients is not simply about providing them with basic health information, but going beyond this to provide information that is truly relevant and of use to them.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

The mobile health entrepreneur: an endangered species?

The mobile health entrepreneur: an endangered species? | Pharma | Scoop.it

What can we learn about the future of mobile health applications by considering the evolution of the website over the last two decades?

more...
Art Jones's curator insight, November 12, 2014 12:37 PM

This is a thought provoking question. When you look at the history of website design and how easy it is to design a modern website, it is reasonable to expect mHealth APS will take the same accelerated path.


One day APS may develop themselves to meet each of our unique mHealth requirements.


 Does The Future = Personalized mhealth APS ?

Scooped by Andrew Spong
Scoop.it!

Millennials want to know how companies are solving social problems

Millennials want to know how companies are solving social problems | Pharma | Scoop.it
The millennial generation care less about corporate philanthropy and big cash donations, and more about how corporations are solving social problems.
Andrew Spong's insight:

It's so disappointing to see this important issue addressed within the context of 'corporate social responsibility'.

 

CSR is a PR-driven locked box within which social good is permitted to be pursued in limited contexts whilst the rest of an organisation maintains destructive practices unchecked.

 

Companies committed to reforming themselves should begin by dissolving their CSR units.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Five steps to building successful digital health interventions

Five steps to building successful digital health interventions | Pharma | Scoop.it

Context. Interoperability. Physician (and patient, presumably) 'engagement'. Evidence. Scale.

Andrew Spong's insight:

All factors worth bearing in mind, certainly, but in a sense this article is simply a reminder that every potential intervention needs to be considered on its merits, and that potentially successful solutions reside in the middle of a complex set of interrelations.

 

Overlooking any one of them is likely to consign your efforts to failure.

 

Oh, and good luck with 'interoperability'.

 

Who can really be said to have 'cracked' this yet, beyond marketing spin?

 

A 'Gordian Knot' solution that addresses the difficulties of legacy providers' EHR interoperability by severing ties with them altogether, and taking a consumer-led view by using the patient's own healthcare records seems only a generation or two of devices away at this point.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Six ways social media affects your clinical trial - whether you like it, or not

Six ways social media affects your clinical trial - whether you like it, or not | Pharma | Scoop.it

Transparency; recruitment; information sharing; advocacy; learning; support.

 

In short, pretty much everything has changed -- and there's both good and bad, from multiple, and often highly challenging perspectives.

more...
XPert Patient's curator insight, December 22, 2014 2:55 AM

I agree that sponsors should consider implementing a formal feedback loop for patients/caregivers to share insights on a clinical trial  in addition to encouraging informal conversations between the investigators and trial enrollees to discuss such issues.


 I was on AML Clinical Trial 15 for treatment for a rare disease called acute promyelocytic leukaemia in 2004/2005. This disease affects one in a million people in Europe. Ten years later I have managed to find three people on twitter who are in remission from this disease. None of them were on AML Clinical Trial 15.


Remember it is not always possible for people with rare diseases to actually find other people who have faced similar challenges. As such, having a formal feedback loop would be an excellent idea for patients/caregivers both during the trial and in the longer long term so that a  network is created from the outset. 

Scooped by Andrew Spong
Scoop.it!

"Social media and real-time support can be done by pharma, and it’s being done right before your eyes"

"Social media and real-time support can be done by pharma, and it’s being done right before your eyes" | Pharma | Scoop.it
Andrew Spong's insight:

Kai Gait, Global Digital Director, GSK, keeping it real, as usual.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Astellas hosts an app-focused Innovation Challenge in association with New Scientist

Astellas hosts an app-focused Innovation Challenge in association with New Scientist | Pharma | Scoop.it

Astellas invites participants to 'Come up with an innovative app for healthy living that impresses [their] judges and your idea could become a reality!'

Andrew Spong's insight:

A positive, progressive idea. Great to see Astellas teaming up with New Scientist for this initiative, too

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

An overview of pharma's health accelerator initiatives and startup support

An overview of pharma's health accelerator initiatives and startup support | Pharma | Scoop.it

Merck, Bayer, GSK, Novartis, Janssen and more are all running digital health accelerator support programmes for startups

more...
Jim Murphy's curator insight, September 12, 2014 8:53 AM

Incubating only works if the seeds get planted.  When these companies actually bring these solutions to market then it will be more than a branding gimmick.  

Scooped by Andrew Spong
Scoop.it!

Apple needs healthcare and medical tech companies to help create reasons to wear their devices

Apple needs healthcare and medical tech companies to help create reasons to wear their devices | Pharma | Scoop.it

Apple is trying create 'an iPod experience' in healthcare driven by its wearables, but Apple's wearables need to do things significant enough to persuade health consumers to carry their products around with them.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Digital health in the EU: moving beyond the pill

Digital health in the EU: moving beyond the pill | Pharma | Scoop.it
mHealth is becoming a driving force in the life sciences on both sides of the Atlantic. This contributed commentary examines how the industry is developing in Europe.
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Patients will trade more personal health info with pharma for more relevant services

Patients will trade more personal health info with pharma for more relevant services | Pharma | Scoop.it
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

A nanotech application that keeps bacteria from sticking to surfaces

A nanotech application that keeps bacteria from sticking to surfaces | Pharma | Scoop.it

A nanotechnology that exerts a repulsive force on bacterial cells and prevents attachment and biofilm formation.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Thingful: a search engine for the Internet of Things

Thingful: a search engine for the Internet of Things | Pharma | Scoop.it
Thingful is a search engine for the Internet of Things, providing a geographical index of where things are, who owns them, and how and why they are used.
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

3D printed meds to be made by pharma and hospitals within five years, and by the public within 10

3D printed meds to be made by pharma and hospitals within five years, and by the public within 10 | Pharma | Scoop.it

UCLan project predicts 3D printed medicine techniques will be used by pharmaceutical firms and hospitals within five years and by the public within a decade.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

On pharma, authenticity, and the expectations of health consumers

On pharma, authenticity, and the expectations of health consumers | Pharma | Scoop.it

Today, consumers of healthcare want authenticity when researching health information, but that means a lot of things to different people.

Andrew Spong's insight:

Rich Meyer makes five compelling points in this concise and useful article. Take a couple of minutes to review it, and reflect on his suggestions (NB one is only relevant to DTC)

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Pharma companies have many apps, relatively few downloads

Pharma companies have many apps, relatively few downloads | Pharma | Scoop.it
more...
Justin Hipps, MBA's curator insight, October 28, 2014 4:39 PM

Read More Here: http://mobihealthnews.com/37637/report-pharma-companies-have-many-apps-relatively-few-downloads/ ;

Tanya Kerr's curator insight, January 23, 6:27 PM

An interesting review of the Apps currently produced by pharmaceutical companies and why they are currently widely downloaded /used are they too specific?

Scooped by Andrew Spong
Scoop.it!

Involving people with lived experience: time to choose, because you can't support this, *and* still attend digital pharma conferences

Involving people with lived experience: time to choose, because you can't support this, *and* still attend digital pharma conferences | Pharma | Scoop.it

"A patient and carer viewpoint [will be] represented in every single session and workshop throughout the day, [and] we will be involving people with lived experience in other areas across the conference, including as speakers, chairs and mentors."

Andrew Spong's insight:

There are many reasons to want to attend healthcare conferences.

 

However, when there are options like this available, it's verging on reprehensible for anyone in the pharmaceutical industry to continue to support the lame duck, 'Usual Suspect' digital pharma conferences that reiterate themselves year after year, celebrating their repetition as though having done the same thing for eight years were an achievement rather than an embarrassment.

 

If you're serious about putting the patient at the centre of what you do, you *have* to go to conferences that put the patient at the centre of their programme -- not ones that pay lip service to 'patient engagement' in the absence of their eponymous subjects, and brazenly focus on patients as 'targets' and 'opportunities' rather than as people.


It's time to choose.


Do the right thing.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Mobile: transcending borders, rendering regulatory frameworks impotent

Mobile: transcending borders, rendering regulatory frameworks impotent | Pharma | Scoop.it

By 2017, 85% of the world’s population is expected to be covered by a commercial mobile signal.

 

Transcending state borders, mobile apps bring about a lot interesting questions for anyone studying regulatory frameworks and state-based policy....

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Six finalists announced in the 'Digital pharmaceutical company of the year' category of the PM Society Digital Media Awards 2014

Six finalists announced in the 'Digital pharmaceutical company of the year' category of the PM Society Digital Media Awards 2014 | Pharma | Scoop.it

Bayer, Boehringer Ingelheim, Genentech (Roche), GSK, Novartis and Sanofi have been shortlisted as finalists in the 'Digital pharmaceutical company of the year' category of this year's PM Society Digital Media Awards

Andrew Spong's insight:

I was pleased that STweM was able to work with our partners Symplur to compile the data behind this year's 'Digital pharmaceutical company of the year' category.

 

Results were derived by collating all tweets published in 2013 using the top ten hashtags in Symplur's Healthcare Hashtag Project associated with ten leading causes of mortality.

 

The top pharma companies within each disease area were identified according to the frequency with which they were mentioned.

 

The final results were determined by subsequently identifying those companies which featured most often in each category, weighting by rank, and ordering accordingly.


The winner will be announced on 25 September. I was kindly asked to present the award by the PM Society, but will be out of the country. PM Society co-chair Carwyn Jones has graciously offered to do the honours in my absence.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Patients, pharma, conferences, and the thorny question of 'Return On Investment' in the social age

Patients, pharma, conferences, and the thorny question of 'Return On Investment' in the social age | Pharma | Scoop.it

The evergreen question of what constitutes 'ROI' for pharma in being seen to actively participate in the healthcare conversation on the social web around conference is addressed from many angles in this @CancerGeek article, which reflects on Thomas Lee of Symplur's recent MedX presentation.

 

Do also be sure to read the productive exchanges in the comments.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

It's time for socially-competent US pharma companies to stop DTC advertising

It's time for socially-competent US pharma companies to stop DTC advertising | Pharma | Scoop.it

Why might socially-competent US pharma companies wish to withdraw from DTC marketing?

 

And which of them are ready to do so?

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Social listening: who, why, what, when, where, and how... in one slide

Social listening: who, why, what, when, where, and how... in one slide | Pharma | Scoop.it
Andrew Spong's insight:

HT @eskimon

more...
No comment yet.